Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Biosense Exercises $75 Million Option for China Rights to Neovacs' Lupus Immunotherapy
Week in Review: Shanghai Henlius to File for Hong Kong IPO at Valuation of Over $1 Billion
Week in Review: Agilent Pays $250 Million to Acquire ACEA and its Cell Therapy Analyzer
Week in Review: WuXi AppTec Files for $1 Billion+ Hong Kong IPO at $13 Billion Valuation
Week in Review: Jiangsu Hansoh to Raise Up to $3 Billion in Hong Kong IPO
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events



November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"